Clinical Trials Logo

Depressive Symptoms clinical trials

View clinical trials related to Depressive Symptoms.

Filter by:

NCT ID: NCT05369429 Recruiting - Cancer Clinical Trials

My Wellbeing Guide: A Novel Tool for Managing Stress and Improving Quality of Life

R37
Start date: December 2, 2022
Phase: N/A
Study type: Interventional

The purpose of this study is to examine the implementation and effectiveness of the psychosocial eHealth intervention, My Wellbeing Guide, on the proposed primary outcome, depressive symptoms, in patients diagnosed with cancer who receive care at Northwestern Medicine and the University of Miami Health System. The intervention includes cognitive behavioral therapy management strategies for health-related stress in the form of animated videos, interactive activities, and written content. The intervention will be delivered via an online application over an 7-week period. Intervention participants will also complete four assessments: baseline (at the beginning of the research study), post-intervention (7 weeks after baseline), a 6-month follow-up, and a 12-month follow up. Participants are randomized into either an intervention application (described above) or a control application (which will provide links to helpful resources for patients with cancer, such as the contact information for cancer support services at Northwestern University and the University of Miami, and the link to the National Cancer Institute website, and the American Cancer Society website.) Control participants will also complete four assessments: baseline (at the beginning of the research study), post-intervention (7 weeks after baseline), a 6-month follow-up, and a 12-month follow up.

NCT ID: NCT05355285 Completed - Clinical trials for Major Depressive Disorder

Type 1 Diabetes and Depression: Role of Brain Glutamate

Start date: January 2011
Phase: N/A
Study type: Interventional

The goal of this study is to examine the effect of chronic and acute hyperglycemia in type 1 diabetes mellitus (T1DM) on brain glutamate levels using magnetic resonance spectroscopy (MRS), and associations of brain glutamate with symptoms of depression.

NCT ID: NCT05351866 Terminated - Depression Clinical Trials

Digital Therapeutic for Adolescent Depressive Symptoms in Hematology, Oncology, and Weight Management

Start date: January 26, 2023
Phase: N/A
Study type: Interventional

The primary aims of the proposed research are to assess the feasibility, acceptability, and preliminary evidence of efficacy of a self-guided, cognitive behavioral therapy (CBT)-based mobile app intervention (SparkRx) for the treatment of adolescents presenting with symptoms of depression in specialty medical care settings (e.g.Hematology/Oncology, Weight Management, etc.) at Children's Health System of Texas (CHST).

NCT ID: NCT05344625 Withdrawn - Anxiety Disorders Clinical Trials

Ketamine-Assisted PsychoTherapy ViAbility in Treating Cancer-related Emotional Distress

KAPTIVATED
Start date: October 31, 2023
Phase: Early Phase 1
Study type: Interventional

The present study will investigate if ketamine-assisted psychotherapy during palliative radiation therapy is safe, feasible, and effective at reducing psychological distress.

NCT ID: NCT05323695 Active, not recruiting - Depressive Symptoms Clinical Trials

Implementation of a Depression Screening Intervention at a Transgender Health Clinic in Thailand

CHIMERA
Start date: October 1, 2021
Phase: N/A
Study type: Interventional

The study aims to develop and implement a depression screening intervention into routine HIV and sexual health service provision at a transgender health clinic in Thailand, and to explore the facilitators, barriers, feasibility and acceptability of the screening implementation.

NCT ID: NCT05313542 Not yet recruiting - Depressive Symptoms Clinical Trials

Physical Activity in the Format of Self-defence Training for Depressive Symptoms

Start date: September 1, 2022
Phase: N/A
Study type: Interventional

Inadequate mental health care capacity is a long-standing issue in Hong Kong (Yang & Mak, 2020). For example, a recent study predicts an additional 12% service need for specialist psychiatric care (Ni et al., 2020). It would be helpful to develop interventions that would ease the high demand of the health care system. Physical activity has been shown to reduce depressive symptoms in a number of studies (Bellón et al., 2021; Josefsson et al., 2014; Kvam et al., 2018; Schuch et al., 2016). Its flexibility and low-cost nature make physical activity a good intervention option for depressed individuals to do it anytime and anywhere. This study aims to investigate the effect of physical activity intervention in the format of self-defence training on depressive symptoms. Around 40 eligible participants with at least moderate level of depressive symptoms will be randomly assigned to the physical activity (PA) group and waitlist (WL) control group. The PA group will receive a 6-week home-based self-defence training programme consisting of 120 min video training (including daily practice time) per week. Self-report questionnaires will be collected at baseline, immediate post-intervention, and 4-week follow up assessments. The primary outcome measure will be the Patient Health Questionnaire-9 to evaluate depression severity. Secondary outcomes will include psychological health symptoms, sleep quality, lifestyle, and quality of life. This research will provide new perspectives on the application of physical activity in the form of self-defence training as an intervention for depressive individuals.

NCT ID: NCT05294614 Recruiting - Depression Clinical Trials

Implementation of a Psychological Online Intervention for Low to Moderate Depression in Primary Health Care

Start date: March 30, 2022
Phase: N/A
Study type: Interventional

Implementation of a psychological online intervention for low to moderate depression in primary care settings.

NCT ID: NCT05293691 Recruiting - Depression Clinical Trials

Efficacy of an Online Self-help Program for Negative Affect and Depression

Start date: April 25, 2022
Phase: N/A
Study type: Interventional

The aim of the study is to test Body, breath & mind (BBM, internet-based self-help program) for its efficacy in reducing depressive symptoms and improving quality of life. BBM combines methods of value-oriented behavioral activation with exercises from the Chinese healing practice Qi Gong,. BBM will be compared to an active control treatment (moodgym) and a waiting list control group. We expect significant differences to the waiting list control group. In comparison to the active control treatment we expect no significant differences.

NCT ID: NCT05285501 Completed - Depression Clinical Trials

Virtual Therapeutic Garden for Depressive Symptoms

Start date: March 15, 2022
Phase: N/A
Study type: Interventional

This study evaluates the addition of virtual therapy intervention in the treatment of depression in the elderly. Half of the participants will receive virtual reality treatment as an addition to physical exercises and psychoeducation, while the other half will receive physical exercises and psychoeducation alone.

NCT ID: NCT05271006 Completed - Depressive Symptoms Clinical Trials

COVID-19 Research: COPE Trial in Health Care Workers

Start date: March 31, 2022
Phase: N/A
Study type: Interventional

The present project is designed to address the problem of elevated depression and stress among health care workers (HCWs). Investigators will test the extent to which a 12-week mobile health aerobic exercise intervention (4 days/week for 20 minutes/day) impacts HCWs reported depression. Investigators propose a 2-arm (exercise and waitlist control) parallel randomised controlled trial, with 560 underactive participants recruited from Providence Health Care. Participants will complete an online questionnaire (baseline and every 2 weeks until week 12, and again at week 24) assessing depressive symptoms (primary outcome), stress, flourishing, resilience, life satisfaction, burnout, work-family spillover, , sleep quality, workplace engagement, and absenteeism (secondary outcomes).